ELV|EPS $12.58 vs $10.89 est (+15.5%)|Rev $49.49B|Net Income $1.76BElevance Health, Inc. posted adjusted earnings per share of $12.58 in the first quarter of 2026, topping Wall Street’s consensus estimate of $10.89 by 15.5%. The health benefits company generated $2.77B in adjusted net income as it navigated a shifting managed care landscape marked by evolving government reimbursement rates and persistent cost pressures across its insurance operations.
The Indianapolis-based insurer reported revenue of $49.49B for the quarter, up 1.5% from the $48.77B recorded in the year-ago period. Health Benefits, the company’s core segment, led performance with $42.49B in revenue, climbing 2.6% year-over-year as Elevance continued to serve a broad membership base across commercial, Medicare Advantage, and Medicaid lines of business.
Total medical membership stood at 45.4M at quarter end, reflecting the company’s scale as one of the nation’s largest health insurers operating across multiple markets and product lines. The membership figure underscores Elevance’s position in a sector facing regulatory scrutiny and heightened competition for both individual and employer-sponsored coverage.
Wall Street analyst sentiment remains mixed, with consensus standing at 10 buy ratings, 13 hold ratings, and 0 sell ratings. The better-than-expected earnings come as health insurers balance premium revenue growth against rising utilization trends and administrative costs in a post-pandemic environment.
A detailed analysis of Elevance Health, Inc.’s quarter follows shortly on AlphaStreet.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.